BMO Upgrades Magna International Following Strong Quarterly Results

Magna International (TSX: MG) reported earnings on May 6th pre market, with the results surprising investors. The company ended the day up 2.23%, showing revenues of $10.18 million with a gross margin of only 15%, while net margin came in at 6%, or $615 million.

A few analysts changed their price targets on Magna after their earnings, with the company now having a consensus 12-month price target of $111.69, up from the $102.85 from last month. Accountability Research Copr has the highest price target at $132 while the lowest sits at $94.83.

Below you can see the most recent analyst changes:

Antimony Resources — sponsored Sponsored · Antimony Resources
  • CFRA raises target price by $10 to $120
  • JP Morgan raises target price to $114 from $110
  • BMO raises target price to $108 from $99
  • Scotiabank raises target price to $115 from $105
  • Citigroup raises price target to $116 from $101

In BMO’s note, their analyst Peter Sklar reiterated his outperform rating and raised his 12-month price target to $108, up from $99, while upping their EBITDA multiple to 6.5x from 6x. Sklar writes that the increase is, “due to Magna’s strong operational performance in Q1/21 and expanding exposure to vehicle electrification and autonomous features.” They also changed their 2021 and 2022 estimates slightly, with them now forecasting second-quarter revenue of $9.42 billion, down from $10.355 billion. BMO then raises their full-year 2021 and 2022 estimates which you can find below.

With every car company right now, Magna’s management reported that the global semiconductor shortage could be prolonged into 2022 which is longer than previously expected, while adding that resin prices are remaining sticky and could be a headwind for the company. Sklar says between these two headwinds, “the resulting negative commodities impact could be as high as US$80M, despite the positive effect of rising scrap prices.”

With Magna reporting better than expected earnings all around, which Sklar attributes to an “outperformance in all segments,” with the company sales growth driven by higher vehicle production, the launch of new programs and the Canadian dollar having a good quarter. Higher than expected EBIT margins were attributed to cost reductions and operating efficiencies from the companies restructuring efforts.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Trending

Related News

Cormark: “Eguana Tech Is At The Very Forefront Of The Growing Wave Of Energy Storage”

Yesterday, Eguana Technologies (TSXV: EGT) released their full year 2020 financial results, alongside an operational...

Friday, January 22, 2021, 11:45:00 AM

Vireo Health: Canaccord Reiterates After Q4 Results

Last week, Vireo Health (CSE: VREO) released their fourth quarter and year-end 2020 financial results....

Monday, March 29, 2021, 04:03:00 PM

Endeavour Mining: Analysts Maintain Price Targets Following Q2 Results

On August 4, Endeavour Mining (TSX: EDV) reported its second quarter financial and production results....

Friday, August 6, 2021, 03:48:00 PM

Medipharm Labs Sees Canaccord Drop Price Target To $0.75

On May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced...

Tuesday, May 18, 2021, 05:32:00 PM

CareRx: Canaccord Raises Price Target To $6.50 Following Financing

Earlier this week, CareRx Corp (TSX: CRRX) closed their C$21.2 million bought deal. Notably, $6.25...

Friday, February 5, 2021, 11:45:00 AM